Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy
Colorectal Cancer Screening in Average-risk Population: a Multicenter, Randomized Control Trial Comparing Immunochemical Fecal Occult Blood Testing Versus Colonoscopy.
Sponsor: Fundacion Cientifica de la Asociacion Española contra el Cancer
A NA clinical study on Colorectal Cancer and Colorectal Neoplasm, this trial is completed. The trial is conducted by Fundacion Cientifica de la Asociacion Española contra el Cancer and has accumulated 9 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Apr 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Apr 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2024 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE3 → NA
▶ Show 4 earlier versions
-
Jan 2022 — Feb 2024 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundacion Cientifica de la Asociacion Española contra el Cancer
- Hospital Clinic of Barcelona
- Instituto de Salud Carlos III
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Barcelona, Spain
- • Madrid, Spain
- • Murcia, Spain
- • Ourense, Spain
- • San Sebastián, Spain
- • Santa Cruz de Tenerife, Spain
- • Valencia, Spain
- • Zaragoza, Spain